In the NSCLC cohort, patients with Central and South American, East Asian, and South Asian ancestry were more highly represented in the RET fusions-positive subset vs the RET fusion-negative subset (8.6% vs 5.1%, 11% vs 4.3%, 1.9% vs 0.6%, respectively, P < 0.001). The gene discussed is RET; the disease is non-small cell lung carcinoma.